Are sugary drinks more harmful to your liver than alcohol? – DR.VEGAN

Are sugary drinks more harmful to your liver than alcohol?

Are sugary drinks more harmful to your liver than alcohol?

Article by Olivier Sanchez ND, NT Dip, Ir

Most people think 'liver damage = too much alcohol.' In reality, one of the fastest‑growing liver problems worldwide today has nothing to do with how often you drink wine or beer. It’s driven instead by everyday habits like sweetened coffees, fizzy drinks, and even so‑called 'diet' sodas.

In my book 'Detox before Energise,' I explain in great detail the impact of excessive sugar intake on liver disease. Here is an extract:

“Gut dysbiosis, obesity, and metabolic disorders have been linked to liver inflammation, which contributes to systemic, low-grade inflammation. Cases of liver disease, such as non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD), and a large spectrum of liver lesions occurring in the context of obesity, type 2 diabetes and metabolic syndrome are also increasing. It is estimated that 25% of American adults and 20% of UK adults have NAFLD. Approximately a quarter of the global population is predicted to be living with NAFLD, a disease which can lead to cirrhosis and liver cancer, with the prevalence increasing alongside the increase in obesity. A diet rich in refined and ultra-processed sugars, coupled with the consumption of hydrogenated and trans-fats, alongside a sedentary lifestyle, stands as a prominent contributor to gut dysbiosis, increased gut permeability (leaky gut syndrome), systemic low-grade inflammation, insulin resistance, type-2 diabetes, obesity, metabolic syndrome, and the presence of endotoxins. These endotoxins are well-known for their role in causing liver inflammation and, therefore, NAFLD.”

MASLD vs NAFLD – same disease, new name 

Until recently, doctors used the term NAFLD (non‑alcoholic fatty liver disease) to describe fat building up in the liver of people who drink little or no alcohol. Because this condition is closely linked to weight, blood sugar, blood pressure, and cholesterol, experts have renamed it MASLD (metabolic dysfunction‑associated steatotic liver disease) to reflect the underlying cause: metabolic stress and insulin resistance, not alcohol. 

MASLD is the updated umbrella term that requires both liver fat and at least one metabolic risk factor (e.g. central obesity, type 2 diabetes, raised triglycerides, high blood pressure). Whichever name is used, the core problem is the same: fat and inflammation slowly build up inside the liver, increasing the risk of cirrhosis, liver cancer, and cardiovascular disease over time.

What the research says about sugary and 'diet' drinks

A growing body of large cohort studies and modelling work shows that high intakes of sugar‑sweetened and artificially sweetened drinks are strongly linked to fatty liver and liver‑related deaths:

US analysis

A major analysis found that drinking ≥1 sugar-sweetened drink per day

was associated with a significantly higher risk of liver cancer and death from chronic liver disease compared with rare consumption.

UK Biobank • 120,000+ adults • Presented at UEG Week 2025

Drinking more than roughly one can per day 

of sugary drinks was linked to about a

50% higher risk of MASLD

while a similar amount of diet/low-sugar drinks was linked to about a

60% higher risk

UK Biobank analysis • Hospitalised NAFLD

Hospital admission risk increases

Found that higher intakes of sugar- and artificially sweetened beverages were associated with increased risk of being admitted with NAFLD over ~10 years of follow-up.

Encouraging news • UK Biobank study

Swapping these drinks for water

Reduced MASLD risk by around

13–15%

Highlighting that what you drink daily truly matters.

Tired of confusing health advice? Let our Virtual Nutritionist simplify it.

How sugary drinks stress your liver

Sugary drinks are uniquely hard on the liver because of how quickly and how much sugar they deliver:

  1. Rapid glucose and fructose load
    Most soft drinks, energy drinks, sweetened coffees, and fruit concentrate juices contain a mix of glucose and fructose, and loads of it. Glucose spikes blood sugar and insulin levels; fructose is largely processed in the liver, where it can be rapidly converted into fat. Excessive fructose metabolism depletes ATP and impairs mitochondrial fat burning, increasing oxidative stress and inflammation in the liver.
  2. Fat accumulation in liver cells 
    Over time, repeated large fructose loads promote triglyceride buildup in liver cells, especially in people with insulin resistance or excess visceral fat. This is the first step toward MASLD/NAFLD.
  3. Insulin resistance and inflammation
    Regular intake of sugary drinks is linked to higher fasting glucose, insulin, and inflammatory markers, all of which drive metabolic dysfunction and promote fat accumulation in the liver.
  4. 'Diet' drinks and the gut
    Artificially sweetened drinks don’t contain sugar, but they may still disrupt the gut microbiome and appetite regulation, which can worsen insulin resistance and metabolic stress. This likely explains why some large datasets show similar or even higher MASLD risk with frequent diet drink intake compared with sugary drinks.

You maybe be interested in learning how stevia and artificial sweeteners impact Iinsulin resistance or discover how cutting back on sugary drinks can positively impact your liver health — and learn simple, practical ways to support your liver for the long term.


This article was written by
Zakia Mance

 You may also enjoy reading:

References
Arab, JP., Arrese, M., Shah, VH. (2020). Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives. Hepatology Research. 50(4), pp. 407-418. doi:10.1111/hepr.13473
Callingham, F. (2024). The UK city ‘so unhealthy’ one in every four locals are addicted to fizzy drinks. Available at: https://www.express.co.uk/life-style/health/1868319/uk-city-addicted-fizzy-drinks. [Accessed: 10 Feb. 2026]
Cassidy, YJ., Chen, C., Cui, J. et al. (2019). Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell Metabolism. 30(4), pp. 675-688.e7. doi:10.1016/j.cmet.2019.08.018
Chen, H., Wang, J., Li, Z. et al. (2019). Consumption of sugar-sweetened beverages has a dose-dependent effect on the risk of non-alcoholic fatty liver disease: An updated systematic review and dose-response meta-analysis. International Journal of Environmental Research and Public Health. 16(12), 2192. doi:10.3390/ijerph16122192
Denova-Gutiérrez, E., Rivera-Paredez, B., Quezada-Sánchez, AD. et al. (2025). Soft drink consumption and increased risk of nonalcoholic fatty liver disease: Results from the health workers cohort study. Annals of Hepatology. 30(1), 101566. doi:10.1016/j.aohep.2024.101566
Fackelmann, G., Manghi, P., Carlino, N. et al. (2025). Gut microbiome signatures of vegan, vegetarian and omnivore diets and associated health outcomes across 21,561 individuals. Nature Microbiology. 10, pp. 41–52 doi:10.1038/s41564-024-01870-z
Fairfield, B., Schnabl, B. (2020). Gut dysbiosis as a driver in alcohol-induced liver injury. JHEP Reports. 3(2), 100220. doi:10.1016/j.jhepr.2020.100220
Geidl-Flueck, B., Gerber, PA. (2023). Fructose drives de novo lipogenesis affecting metabolic health. Journal of Endocrinology. 257(2), e220270. doi:10.1530/JOE-22-0270
Herman, MA., Samuel, VT. (2016). The sweet path to metabolic demise: Fructose and lipid synthesis. Trends in Endocrinology and Metabolism. 27(10), pp. 719-730. doi:10.1016/j.tem.2016.06.005
Kirpich, IA., Parajuli, D., McClain, CJ. (2015). Microbiome in NAFLD and ALD. Clinical Liver Disease (Hoboken). 6(3), pp. 55-58. doi:10.1002/cld.494
Le, P., Tatar, M., Dasarathy, S. et al. (2025). Estimated burden of metabolic dysfunction-associated steatotic liver disease in US adults, 2020 to 2050. JAMA Network Open. 8(1), e2454707. doi:10.1001/jamanetworkopen.2024.54707
Liu, L., et al. Sugar- and low/non-sugar-sweetened beverages and risks of metabolic dysfunction-associated steatotic liver disease and liver-related mortality: A prospective analysis of the UK Biobank. Abstract OP161. UEG Week 2025, 4-7th October 2025.
Meijnikman, AS., Davids, M., Herrema, H. et al. (2022). Microbiome-derived ethanol in nonalcoholic fatty liver disease. Nature Medicine. 28(10), pp. 2100-2106. doi:10.1038/s41591-022-02016-6
NHS (2022). Non-alcoholic fatty liver disease (NAFLD). Available at: https://www.nhs.uk/conditions/non-alcoholic-fatty-liver-disease [Accessed: 10 Feb. 2026]
Ouyang, X., Cirillo, P., Sautin, Y. et al. (2008). Fructose consumption as a risk factor for non-alcoholic fatty liver disease. Journal of Hepatology. 48(6), pp. 993-999. doi:10.1016/j.jhep.2008.02.011
Sidhu, SRK., Kok, CW., Kunasegaran, T. et al. (2023). Effect of plant-based diets on gut microbiota: A systematic review of interventional studies. Nutrients. 15(6), 1510. doi:10.3390/nu15061510
Softic, S., Cohen, DE., Kahn, CR. (2016). Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease. Digestive Diseases and Sciences. 61(5), pp. 1282-1293. doi:10.1007/s10620-016-4054-0
Wu, SY., Bo, YC., Li, ZY. et al. (2025). EAT-Lancet diet and risk of metabolic dysfunction-associated steatotic liver disease and other liver chronic diseases: A large prospective cohort study in the UK Biobank. Frontiers in Nutrition. 12, 1589424. doi:10.3389/fnut.2025.1589424
Sun, Y., Yu, B., Wang, Y. et al. (2023). Associations of sugar-sweetened beverages, artificially sweetened beverages, and pure fruit juice with nonalcoholic fatty liver disease: Cross-sectional and longitudinal study. Endocrine Practice. 29(9), pp. 735-742. doi:10.1016/j.eprac.2023.06.002
Younossi, ZM., Golabi, P., Price, JK. et al. (2024). The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes. Clinical Gastroenterology and Hepatology. 22(10), pp. 1999-2010.e8. doi:10.1016/j.cgh.2024.03.006
Younossi, ZM., Kalligeros, M., Henry, L. et al. (2025). Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology. 31, S32-S50. doi:10.3350/cmh.2024.0431
Zakir-Hussain, M. (2025). Liver disease warning issued over ingredients found in ‘diet’ drinks. The Independent. Available at: https://www.independent.co.uk/news/health/diet-drinks-artificial-sweeteners-liver-disease-warning-ssbs-b2841445.html [Accessed 10 Feb. 2026]
Zhao, L., Zhang, X., Coday, M. et al. (2023). Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Liver Cancer and Chronic Liver Disease Mortality. JAMA. 2023 Aug 8;330(6):537-546. doi: 10.1001/jama.2023.12618. PMID: 37552302; PMCID: PMC10410478.
Zhu, L., Baker, RD., Zhu, R. et al. (2016). Gut microbiota produce alcohol and contribute to NAFLD. Gut. 65(7), 1232. doi:10.1136/gutjnl-2016-311571
 

Basket

Your shopping basket is empty. Wondering which supplement you should take?
Our expert Nutritionists are here to assist you.

Book now

Add to your stack

Gut Works®

Gut Works®

(410)
£32.99

Vegan Omega 3

Vegan Omega 3

(72)
£21.99

Magnesium Glycinate

Subtotal

£0.00

Shipping and taxes calculated at checkout.